Twist Bioscience Corporation (TWST) Misses Q4 EPS by 5c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.84), $0.05 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $38 million versus the consensus estimate of $37.02 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2022 revenue of $183-193 million, versus the consensus of $131.11 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Piper Sandler Starts Twist Bioscience (TWST) at Overweight
• Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue